1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Monoclonal Antibodies Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Production Method
6.1 In Vivo
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 In Vitro
6.2.1 Market Trends
6.2.2 Market Forecast
7 Market Breakup by Source
7.1 Murine
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Chimeric
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Humanized
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Human
7.4.1 Market Trends
7.4.2 Market Forecast
8 Market Breakup by Indication
8.1 Cancer
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Autoimmune Diseases
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Inflammatory Diseases
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Infectious Diseases
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Others
8.5.1 Market Trends
8.5.2 Market Forecast
9 Market Breakup by End Use
9.1 Hospitals
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Research Institutes
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Others
9.3.1 Market Trends
9.3.2 Market Forecast
10 Market Breakup by Region
10.1 North America
10.1.1 United States
10.1.1.1 Market Trends
10.1.1.2 Market Forecast
10.1.2 Canada
10.1.2.1 Market Trends
10.1.2.2 Market Forecast
10.2 Asia-Pacific
10.2.1 China
10.2.1.1 Market Trends
10.2.1.2 Market Forecast
10.2.2 Japan
10.2.2.1 Market Trends
10.2.2.2 Market Forecast
10.2.3 India
10.2.3.1 Market Trends
10.2.3.2 Market Forecast
10.2.4 South Korea
10.2.4.1 Market Trends
10.2.4.2 Market Forecast
10.2.5 Australia
10.2.5.1 Market Trends
10.2.5.2 Market Forecast
10.2.6 Indonesia
10.2.6.1 Market Trends
10.2.6.2 Market Forecast
10.2.7 Others
10.2.7.1 Market Trends
10.2.7.2 Market Forecast
10.3 Europe
10.3.1 Germany
10.3.1.1 Market Trends
10.3.1.2 Market Forecast
10.3.2 France
10.3.2.1 Market Trends
10.3.2.2 Market Forecast
10.3.3 United Kingdom
10.3.3.1 Market Trends
10.3.3.2 Market Forecast
10.3.4 Italy
10.3.4.1 Market Trends
10.3.4.2 Market Forecast
10.3.5 Spain
10.3.5.1 Market Trends
10.3.5.2 Market Forecast
10.3.6 Russia
10.3.6.1 Market Trends
10.3.6.2 Market Forecast
10.3.7 Others
10.3.7.1 Market Trends
10.3.7.2 Market Forecast
10.4 Latin America
10.4.1 Brazil
10.4.1.1 Market Trends
10.4.1.2 Market Forecast
10.4.2 Mexico
10.4.2.1 Market Trends
10.4.2.2 Market Forecast
10.4.3 Others
10.4.3.1 Market Trends
10.4.3.2 Market Forecast
10.5 Middle East and Africa
10.5.1 Market Trends
10.5.2 Market Breakup by Country
10.5.3 Market Forecast
11 SWOT Analysis
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 AbbVie Inc.
15.3.1.1 Company Overview
15.3.1.2 Product Portfolio
15.3.1.3 Financials
15.3.1.4 SWOT Analysis
15.3.2 Amgen Inc.
15.3.2.1 Company Overview
15.3.2.2 Product Portfolio
15.3.2.3 Financials
15.3.2.4 SWOT Analysis
15.3.3 Biogen Inc.
15.3.3.1 Company Overview
15.3.3.2 Product Portfolio
15.3.3.3 Financials
15.3.3.4 SWOT Analysis
15.3.4 F. Hoffmann-La Roche AG
15.3.4.1 Company Overview
15.3.4.2 Product Portfolio
15.3.4.3 Financials
15.3.5 GSK plc
15.3.5.1 Company Overview
15.3.5.2 Product Portfolio
15.3.5.3 Financials
15.3.5.4 SWOT Analysis
15.3.6 Johnson & Johnson
15.3.6.1 Company Overview
15.3.6.2 Product Portfolio
15.3.6.3 Financials
15.3.6.4 SWOT Analysis
15.3.7 Merck KGaA
15.3.7.1 Company Overview
15.3.7.2 Product Portfolio
15.3.7.3 Financials
15.3.7.4 SWOT Analysis
15.3.8 Novartis AG
15.3.8.1 Company Overview
15.3.8.2 Product Portfolio
15.3.8.3 Financials
15.3.8.4 SWOT Analysis
15.3.9 Novo Nordisk A/S
15.3.9.1 Company Overview
15.3.9.2 Product Portfolio
15.3.9.3 Financials
15.3.9.4 SWOT Analysis
15.3.10 Pfizer Inc.
15.3.10.1 Company Overview
15.3.10.2 Product Portfolio
15.3.10.3 Financials
15.3.10.4 SWOT Analysis
15.3.11 Sanofi S.A.
15.3.11.1 Company Overview
15.3.11.2 Product Portfolio
15.3.11.3 Financials
15.3.11.4 SWOT Analysis
15.3.12 Thermo Fisher Scientific Inc.
15.3.12.1 Company Overview
15.3.12.2 Product Portfolio
15.3.12.3 Financials
15.3.12.4 SWOT Analysis
List of Figures
Figure 1: Global: Monoclonal Antibodies Market: Major Drivers and Challenges
Figure 2: Global: Monoclonal Antibodies Market: Sales Value (in Billion USD), 2018-2023
Figure 3: Global: Monoclonal Antibodies Market Forecast: Sales Value (in Billion USD), 2024-2032
Figure 4: Global: Monoclonal Antibodies Market: Breakup by Production Method (in %), 2023
Figure 5: Global: Monoclonal Antibodies Market: Breakup by Source (in %), 2023
Figure 6: Global: Monoclonal Antibodies Market: Breakup by Indication (in %), 2023
Figure 7: Global: Monoclonal Antibodies Market: Breakup by End Use (in %), 2023
Figure 8: Global: Monoclonal Antibodies Market: Breakup by Region (in %), 2023
Figure 9: Global: Monoclonal Antibodies (In Vivo) Market: Sales Value (in Million USD), 2018 & 2023
Figure 10: Global: Monoclonal Antibodies (In Vivo) Market Forecast: Sales Value (in Million USD), 2024-2032
Figure 11: Global: Monoclonal Antibodies (In Vitro) Market: Sales Value (in Million USD), 2018 & 2023
Figure 12: Global: Monoclonal Antibodies (In Vitro) Market Forecast: Sales Value (in Million USD), 2024-2032
Figure 13: Global: Monoclonal Antibodies (Murine) Market: Sales Value (in Million USD), 2018 & 2023
Figure 14: Global: Monoclonal Antibodies (Murine) Market Forecast: Sales Value (in Million USD), 2024-2032
Figure 15: Global: Monoclonal Antibodies (Chimeric) Market: Sales Value (in Million USD), 2018 & 2023
Figure 16: Global: Monoclonal Antibodies (Chimeric) Market Forecast: Sales Value (in Million USD), 2024-2032
Figure 17: Global: Monoclonal Antibodies (Humanized) Market: Sales Value (in Million USD), 2018 & 2023
Figure 18: Global: Monoclonal Antibodies (Humanized) Market Forecast: Sales Value (in Million USD), 2024-2032
Figure 19: Global: Monoclonal Antibodies (Human) Market: Sales Value (in Million USD), 2018 & 2023
Figure 20: Global: Monoclonal Antibodies (Human) Market Forecast: Sales Value (in Million USD), 2024-2032
Figure 21: Global: Monoclonal Antibodies (Cancer) Market: Sales Value (in Million USD), 2018 & 2023
Figure 22: Global: Monoclonal Antibodies (Cancer) Market Forecast: Sales Value (in Million USD), 2024-2032
Figure 23: Global: Monoclonal Antibodies (Autoimmune Diseases) Market: Sales Value (in Million USD), 2018 & 2023
Figure 24: Global: Monoclonal Antibodies (Autoimmune Diseases) Market Forecast: Sales Value (in Million USD), 2024-2032
Figure 25: Global: Monoclonal Antibodies (Inflammatory Diseases) Market: Sales Value (in Million USD), 2018 & 2023
Figure 26: Global: Monoclonal Antibodies (Inflammatory Diseases) Market Forecast: Sales Value (in Million USD), 2024-2032
Figure 27: Global: Monoclonal Antibodies (Infectious Diseases) Market: Sales Value (in Million USD), 2018 & 2023
Figure 28: Global: Monoclonal Antibodies (Infectious Diseases) Market Forecast: Sales Value (in Million USD), 2024-2032
Figure 29: Global: Monoclonal Antibodies (Other Indications) Market: Sales Value (in Million USD), 2018 & 2023
Figure 30: Global: Monoclonal Antibodies (Other Indications) Market Forecast: Sales Value (in Million USD), 2024-2032
Figure 31: Global: Monoclonal Antibodies (Hospitals) Market: Sales Value (in Million USD), 2018 & 2023
Figure 32: Global: Monoclonal Antibodies (Hospitals) Market Forecast: Sales Value (in Million USD), 2024-2032
Figure 33: Global: Monoclonal Antibodies (Research Institutes) Market: Sales Value (in Million USD), 2018 & 2023
Figure 34: Global: Monoclonal Antibodies (Research Institutes) Market Forecast: Sales Value (in Million USD), 2024-2032
Figure 35: Global: Monoclonal Antibodies (Other End Uses) Market: Sales Value (in Million USD), 2018 & 2023
Figure 36: Global: Monoclonal Antibodies (Other End Uses) Market Forecast: Sales Value (in Million USD), 2024-2032
Figure 37: North America: Monoclonal Antibodies Market: Sales Value (in Million USD), 2018 & 2023
Figure 38: North America: Monoclonal Antibodies Market Forecast: Sales Value (in Million USD), 2024-2032
Figure 39: United States: Monoclonal Antibodies Market: Sales Value (in Million USD), 2018 & 2023
Figure 40: United States: Monoclonal Antibodies Market Forecast: Sales Value (in Million USD), 2024-2032
Figure 41: Canada: Monoclonal Antibodies Market: Sales Value (in Million USD), 2018 & 2023
Figure 42: Canada: Monoclonal Antibodies Market Forecast: Sales Value (in Million USD), 2024-2032
Figure 43: Asia-Pacific: Monoclonal Antibodies Market: Sales Value (in Million USD), 2018 & 2023
Figure 44: Asia-Pacific: Monoclonal Antibodies Market Forecast: Sales Value (in Million USD), 2024-2032
Figure 45: China: Monoclonal Antibodies Market: Sales Value (in Million USD), 2018 & 2023
Figure 46: China: Monoclonal Antibodies Market Forecast: Sales Value (in Million USD), 2024-2032
Figure 47: Japan: Monoclonal Antibodies Market: Sales Value (in Million USD), 2018 & 2023
Figure 48: Japan: Monoclonal Antibodies Market Forecast: Sales Value (in Million USD), 2024-2032
Figure 49: India: Monoclonal Antibodies Market: Sales Value (in Million USD), 2018 & 2023
Figure 50: India: Monoclonal Antibodies Market Forecast: Sales Value (in Million USD), 2024-2032
Figure 51: South Korea: Monoclonal Antibodies Market: Sales Value (in Million USD), 2018 & 2023
Figure 52: South Korea: Monoclonal Antibodies Market Forecast: Sales Value (in Million USD), 2024-2032
Figure 53: Australia: Monoclonal Antibodies Market: Sales Value (in Million USD), 2018 & 2023
Figure 54: Australia: Monoclonal Antibodies Market Forecast: Sales Value (in Million USD), 2024-2032
Figure 55: Indonesia: Monoclonal Antibodies Market: Sales Value (in Million USD), 2018 & 2023
Figure 56: Indonesia: Monoclonal Antibodies Market Forecast: Sales Value (in Million USD), 2024-2032
Figure 57: Others: Monoclonal Antibodies Market: Sales Value (in Million USD), 2018 & 2023
Figure 58: Others: Monoclonal Antibodies Market Forecast: Sales Value (in Million USD), 2024-2032
Figure 59: Europe: Monoclonal Antibodies Market: Sales Value (in Million USD), 2018 & 2023
Figure 60: Europe: Monoclonal Antibodies Market Forecast: Sales Value (in Million USD), 2024-2032
Figure 61: Germany: Monoclonal Antibodies Market: Sales Value (in Million USD), 2018 & 2023
Figure 62: Germany: Monoclonal Antibodies Market Forecast: Sales Value (in Million USD), 2024-2032
Figure 63: France: Monoclonal Antibodies Market: Sales Value (in Million USD), 2018 & 2023
Figure 64: France: Monoclonal Antibodies Market Forecast: Sales Value (in Million USD), 2024-2032
Figure 65: United Kingdom: Monoclonal Antibodies Market: Sales Value (in Million USD), 2018 & 2023
Figure 66: United Kingdom: Monoclonal Antibodies Market Forecast: Sales Value (in Million USD), 2024-2032
Figure 67: Italy: Monoclonal Antibodies Market: Sales Value (in Million USD), 2018 & 2023
Figure 68: Italy: Monoclonal Antibodies Market Forecast: Sales Value (in Million USD), 2024-2032
Figure 69: Spain: Monoclonal Antibodies Market: Sales Value (in Million USD), 2018 & 2023
Figure 70: Spain: Monoclonal Antibodies Market Forecast: Sales Value (in Million USD), 2024-2032
Figure 71: Russia: Monoclonal Antibodies Market: Sales Value (in Million USD), 2018 & 2023
Figure 72: Russia: Monoclonal Antibodies Market Forecast: Sales Value (in Million USD), 2024-2032
Figure 73: Others: Monoclonal Antibodies Market: Sales Value (in Million USD), 2018 & 2023
Figure 74: Others: Monoclonal Antibodies Market Forecast: Sales Value (in Million USD), 2024-2032
Figure 75: Latin America: Monoclonal Antibodies Market: Sales Value (in Million USD), 2018 & 2023
Figure 76: Latin America: Monoclonal Antibodies Market Forecast: Sales Value (in Million USD), 2024-2032
Figure 77: Brazil: Monoclonal Antibodies Market: Sales Value (in Million USD), 2018 & 2023
Figure 78: Brazil: Monoclonal Antibodies Market Forecast: Sales Value (in Million USD), 2024-2032
Figure 79: Mexico: Monoclonal Antibodies Market: Sales Value (in Million USD), 2018 & 2023
Figure 80: Mexico: Monoclonal Antibodies Market Forecast: Sales Value (in Million USD), 2024-2032
Figure 81: Others: Monoclonal Antibodies Market: Sales Value (in Million USD), 2018 & 2023
Figure 82: Others: Monoclonal Antibodies Market Forecast: Sales Value (in Million USD), 2024-2032
Figure 83: Middle East and Africa: Monoclonal Antibodies Market: Sales Value (in Million USD), 2018 & 2023
Figure 84: Middle East and Africa: Monoclonal Antibodies Market: Breakup by Country (in %), 2023
Figure 85: Middle East and Africa: Monoclonal Antibodies Market Forecast: Sales Value (in Million USD), 2024-2032
Figure 86: Global: Monoclonal Antibodies Industry: SWOT Analysis
Figure 87: Global: Monoclonal Antibodies Industry: Value Chain Analysis
Figure 88: Global: Monoclonal Antibodies Industry: Porter's Five Forces Analysis
List of Tables
Table 1: Global: Monoclonal Antibodies Market: Key Industry Highlights, 2023 and 2032
Table 2: Global: Monoclonal Antibodies Market Forecast: Breakup by Production Method (in Million USD), 2024-2032
Table 3: Global: Monoclonal Antibodies Market Forecast: Breakup by Source (in Million USD), 2024-2032
Table 4: Global: Monoclonal Antibodies Market Forecast: Breakup by Indication (in Million USD), 2024-2032
Table 5: Global: Monoclonal Antibodies Market Forecast: Breakup by End Use (in Million USD), 2024-2032
Table 6: Global: Monoclonal Antibodies Market Forecast: Breakup by Region (in Million USD), 2024-2032
Table 7: Global: Monoclonal Antibodies Market: Competitive Structure
Table 8: Global: Monoclonal Antibodies Market: Key Players